Mark Kessel's Net Worth
$57.2 Million
Who is Mark Kessel?
Mark Kessel has an estimated net worth of $57.2 Million. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, ORGANOVO HOLDINGS, INC., OXIGENE INC, ANTIGENICS INC /DE/, and Alexza Pharmaceuticals Inc..
SEC CIK
Mark Kessel's CIK is 0001222013
Past Insider Trading and Trends
2005 was Mark Kessel's most active year for acquiring shares with 5 total transactions. Mark Kessel's most active month to acquire stocks was the month of December. 2010 was Mark Kessel's most active year for disposing of shares, totalling 1 transactions. Mark Kessel's most active month to dispose stocks was the month of March. 2009 saw Mark Kessel paying a total of $12,514,200.00 for 10,050,000 shares, this is the most they've acquired in one year. In 2012 Mark Kessel cashed out on 6,000,000 shares for a total of $28,356,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -66.43% | -6.00M |
$4.73 | -$28,356,000.00 | 3.03M |
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +8.28% | 690.63K |
—
|
—
| 9.03M |
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ORGANOVO HOLDINGS, INC. (ONVO) Snapshot price: $0.9899
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OXIGENE INC (OTLC) Snapshot price: $0.03975
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +27.78% | 25K |
$0.23 | $5,750.00 | 115K |
Jan 2
| |||
Form 4
| +0.09% | 25K |
$0.38 | $9,502.50 | 27.3M |
Jul 1
| |||
Form 4
| +116.67% | 35K |
$1.14 | $39,900.00 | 65K |
Jan 2
| |||
Form 4
|
∞
| 30K |
$1.14 | $34,200.00 | 30K |
Dec 8
| |||
Form 4
| +58.42% | 10M |
$1.25 | $12,480,000.00 | 27.12M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANTIGENICS INC /DE/ (AGEN) Snapshot price: $0.6851
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8 - Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
| No matching records found | |||||||||
Alexza Pharmaceuticals Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||